SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

10-08 Sales and Revenue Release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
28/09/26	€0.0902	+0.22%	194,406
25/09/26	€0.0900	0.00%	307,632
24/09/26	€0.0900	+0.78%	306,578
23/09/26	€0.0893	-1.65%	342,650
22/09/26	€0.0908	-0.22%	359,284

Real-time Euronext Paris

More quotes

Market Closed - Euronext Paris 19:55:00 28/09/2026 +04			5-day change	1st Jan Change
0.0902 ^EUR	+0.22%		-0.88%	-10.69%

09-09	SpineGuard SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	SpineGuard says it can cover its funding needs through the second quarter of 2027

Market Cap	8.72M 9.91M 8.24M 7.48M 14.04M 952M 14.13M 98.72M 38.12M 486M 37.22M 36.41M 1.56B	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	8.45M 9.61M 7.99M 7.25M 13.62M 923M 13.7M 95.71M 36.96M 471M 36.09M 35.3M 1.51B	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.13%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Euronext Paris	ALSGD	Real-time
Deutsche Boerse AG	6W5	Delayed
Börse Stuttgart	6W5	Delayed
Boerse Muenchen	6W5	Real-time

09-09	SpineGuard SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-09	SpineGuard says it can cover its funding needs through the second quarter of 2027
09-04	Weekly earnings calendar: Oracle vs Adobe, a battle of old hands
08-25	SpineGuard Wins US Patent for Robotic Ultrasound Technology	MT
08-24	Spineguard Obtains New U.S. Patent for Innovative Ultrasound Technology Designed to Determine Entry Point and Pedicular Drilling Trajectory	CI
08-24	SpineGuard lands a new US patent in spinal guidance
07-28	SpineGuard, Omnia Medical Obtain New US Patent for Dynamic Surgical Guidance Technology	MT
07-27	SpineGuard And Omnia Medical Obtain Notice Of Allowance For U.S. Patent Application For Innovative Application Of DSG Technology To Sacroiliac Joint Fusion	CI
07-27	SpineGuard Secures a New Patent in the United States
07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07-07	Zonebourse earnings calendar for company results: July 8, 2026
05-27	SpineGuard Secures Three Patent Applications in US	MT
05-26	SpineGuard granted three new patents in the United States

SpineGuard Stock

Stocks

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news: SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Price Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

09-09	SpineGuard Reports 2026 Half-Year Results	BU
08-24	SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory	BU
07-27	SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion	BU
07-08	SpineGuard Announces its H1 2026 Revenue	BU
05-26	SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology	BU

09-09	SpineGuard estime pouvoir couvrir ses besoins de financement jusqu'au deuxième trimestre 2027
09-09	SpineGuard annonce ses résultats semestriels 2026
09-04	Agenda Zonebourse des résultats de sociétés : semaine du 7 au 11 septembre 2026
09-04	Agenda des résultats de la semaine : Oracle vs Adobe, duel d'anciens
08-25	Paris avance sur la pointe des pieds avant Nvidia et Jackson Hole

1 day	+0.22%
1 week	-0.88%
Current month	-9.71%
1 month	-6.04%
3 months	+10.00%
6 months	-20.88%
Current year	-10.69%

1 week	0.09	0.1
1 month	0.09	0.14
Current year	0.08	0.14
1 year	0.08	0.3
3 years	0.08	0.42
5 years	0.08	1.67
10 years	0.08	5.29

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	15/02/2020
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	01/01/2009
Thibault Chandanson CTO	Chief Tech/Sci/R&D Officer	-	01/09/2019

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	16/01/2009
Maurice Bourlion BRD	Director/Board Member	-	02/07/2009
Pierre Jérôme CHM	Chairman	-	01/03/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	+0.22%	-0.88%	+0.22%	-69.53%	9.94M
PENUMBRA, INC.	-0.12%	+0.03%	+26.72%	+29.21%	12.56B
GETINGE AB	+3.33%	+4.24%	+23.95%	+31.41%	6.67B
ASAHI INTECC CO., LTD.	-3.03%	-0.31%	+35.28%	+20.59%	5.68B
MINIMED GROUP, INC.	+1.55%	-3.88%	-	-	5.62B
APT MEDICAL INC.	+2.47%	+0.78%	-23.55%	+34.51%	4.9B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	-0.19%	+0.46%	-31.20%	-23.12%	3.91B
NOVOCURE LIMITED	-0.25%	-3.93%	+22.91%	-4.51%	1.84B
IMPLANTICA AG	+2.71%	+5.39%	-7.76%	+185.18%	1.69B
NAKANISHI INC.	-1.84%	+98.61%	+191.67%	+67.50%	1.59B
Average	+0.48%	-1.23%	+26.47%	+30.14%	4.45B
Weighted average by Cap.	+0.55%	-0.44%	+20.37%	+30.43%

	2024	2025
Net sales	4.65M 5.28M 4.4M 3.99M 7.49M 507M 7.53M 52.63M 20.32M 259M 19.84M 19.41M 832M	3.76M 4.27M 3.55M 3.22M 6.05M 410M 6.09M 42.54M 16.43M 209M 16.04M 15.69M 672M
Net income	-3.08M -3.5M -2.91M -2.64M -4.96M -336M -4.99M -34.89M -13.48M -172M -13.16M -12.87M -552M	-2.07M -2.35M -1.96M -1.77M -3.33M -226M -3.35M -23.41M -9.04M -115M -8.83M -8.63M -370M
Net Debt	1.82M 2.07M 1.72M 1.56M 2.93M 198M 2.95M 20.59M 7.95M 101M 7.76M 7.6M 325M	-265K -302K -251K -228K -427K -28.96M -430K -3M -1.16M -14.78M -1.13M -1.11M -47.49M